ACID BASE DISORDERS IN CHRONIC LIVER DISEASE CHILD CLASS B AND C ITS CORELATION WITH IN-HOSPITAL MORTALITY

Autores

  • Ch Umer Waqas Azad Fauji Foundation Hospital
  • Zubia Jamil Foundation University Medical College, Fauji Foundation Hospital

DOI:

https://doi.org/10.18623/rvd.v23.5951

Palavras-chave:

Chronic Liver Disease, Liver Cirrhosis, Acid-Base Imbalance, Metabolic Acidosis, Respiratory Alkalosis

Resumo

Background: Chronic liver disease (CLD) is a significant health burden in the world with high morbidity and mortality. The acid-base disorders (ABDs) are common in patients with a high liver disease and can lead to adverse clinical results. There is however limited information on their prevalence and prognostic effect in developing nations such as Pakistan. Objective: To identify the rate of acid-base disorders in chronic liver disease patients and to examine how these disorders relate to in-hospital mortality. Methodology: The study will be a descriptive study that will be carried out in the Department of General Medicine of the Fauji foundation hospital, Rawalpindi from October 2025 to January 2026. A sample size of 100 patients aged between 18 to 65 years with diagnosed CLD (Child-Pugh Class B and C) will be sampled through non-probability consecutive sampling. Arterial blood gas (ABG) will be used to determine acid-base status. The patients will be monitored within a period of 28 days to determine mortality. The analysis of data will be done under SPSS version 25. Results: It is believed that acid-base disorders especially the metabolic acidosis and respiratory alkalosis will be very common and greatly linked to high mortality. Summary: There is the possibility of early detection and treatment of acid-base disorders in CLD patients, which will positively affect the clinical outcomes and decrease mortality.

Referências

Achanti, A.; Szerlip, H. M. Acid-base disorders in the critically ill patient. Clinical Journal of the American Society of Nephrology, 2023, 18(1): 102–112.

Angeli, P.; Bernardi, M.; Villanueva, C. et al. Evolving concepts in decompensated cirrhosis. Journal of Hepatology, 2023, 78(2): 1–15.

Drolz, A.; Horvatits, T.; Roedl, K.; Rutter, K.; Brunner, R.; Zauner, C. et al. Acid-base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease. Annals of Intensive Care, 2018, 8(1): 48.

Drolz, A.; Horvatits, T.; Roedl, K.; Rutter, K.; Brunner, R.; Zauner, C. et al. Acid-base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease. Annals of Intensive Care, 2018, 8(1): 48.

Emmett, M. Review of clinical disorders causing metabolic acidosis. Advances in Chronic Kidney Disease, 2022, 29(4): 355–363.

Fadlallah, H.; El Masri, D.; Bahmad, H. F.; Abou-Kheir, W.; El Masri, J. Update on the complications and management of liver cirrhosis. Medical Sciences, 2025, 13(1): 1–5.

Gottfriedová, H.; Lánská, V.; Jabor, A.; Čáslavská, M.; Špičák, J.; Horáčková, M. et al. Spironolactone-furosemide combination therapy and acid-base disorders in liver cirrhosis patients. International Journal of Clinical Pharmacology and Therapeutics, 2020, 58(5): 261–267.

Gurnani, V.; Kumar, N.; Khan, S.; Nawaz, M. U.; Ahmed, H.; Naz, S. et al. Biochemical risk factors associated with hyperkalemia in cirrhotic patients. Cureus, 2021, 13(9): e18356.

Hernaez, R.; Ge, P. S.; Bajaj, J. S. et al. Prognostic models in cirrhosis: AASLD practice guidance. Hepatology, 2022, 76(1): 1–20.

Jiménez, J. V.; Carrillo-Pérez, D. L.; Rosado-Canto, R. et al. Electrolyte and acid-base disturbances in end-stage liver disease: A physiopathological approach. Digestive Diseases and Sciences, 2017, 62(8): 1855–1871.

Katopodis, P.; Pappas, E. M.; Katopodis, K. P. Acid-base abnormalities and liver dysfunction. Annals of Hepatology, 2022, 27(2): 100675.

Katopodis, P.; Pappas, E. M.; Katopodis, K. P. Acid-base abnormalities and liver dysfunction. Annals of Hepatology, 2022, 27(2): 100675.

Liu, Z. P.; Ouyang, G. Q.; Huang, G. Z.; Wei, J.; Dai, L.; He, S. Q.; Yuan, G. D. Global burden of cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease, 1990–2019. World Journal of Hepatology, 2023, 15(11): 1210–1225.

Mannion, R.; Fitzpatrick, E. Systemic complications secondary to chronic liver disease. Indian Journal of Pediatrics, 2024, 91(3): 286–293.

Moreau, R.; Jalan, R.; Gines, P. et al. Acute-on-chronic liver failure is a distinct clinical syndrome. Journal of Hepatology, 2020, 73(6): e1–e9.

Scheiner, B.; Lindner, G.; Reiberger, T. et al. Acid-base disorders in liver disease. Journal of Hepatology, 2017, 67(5): 1062–1073.

Xu, E. J.; Zarm, A. M.; Lecker, S. H.; Hoenig, M. P. Acid-base disorders in cirrhosis. Advances in Chronic Kidney Disease, 2023, 30(4): 336–342.

Xu, J. H.; Yu, Y. Y.; Xu, X. Y. Management of chronic liver diseases and cirrhosis: current status and future directions. Chinese Medical Journal, 2020, 133(22): 2647–2649.

Downloads

Publicado

2026-03-08

Como Citar

Azad, C. U. W., & Jamil, Z. (2026). ACID BASE DISORDERS IN CHRONIC LIVER DISEASE CHILD CLASS B AND C ITS CORELATION WITH IN-HOSPITAL MORTALITY. Veredas Do Direito , 23(6), e235951. https://doi.org/10.18623/rvd.v23.5951